Comparison

TIE-2/VEGFR-2 kinase-IN-1 European Partner

Item no. HY-112294-25mg
Manufacturer MedChem Express
CASRN 453590-24-4
Amount 25 mg
Quantity options 100 mg 10mM/1mL 10 mg 1 mg 25 mg 50 mg 5 mg
Specific against other
Purity 99.91
Citations [1]Jerry Leroy Adams, et al. Furo-and thienopyrimidine derivatives as angiogenesis inhibitors. Patent WO2003022852.
Smiles NC1=C2C(OC(C3=CC=C(OC)C=C3)=C2)=NC=N1
Available
Product Description
TIE-2/VEGFR-2 kinase-IN-1 is used for the synthesis of TIE-2 and/or VEGFR-2 inhibitors, extracted from patent WO2003022852, example 14. TIE-2/VEGFR-2 kinase-IN-1 is used for the study of diseases associated with inappropriate angiogenesis[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
MolecularWeight
241.25
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer; Inflammation/Immunology; Cardiovascular Disease
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 80°C)
Target
Tie; VEGFR
Manufacturers Target
Tie; VEGFR
Isoform
Tie2
Manufacturers Pathway
Protein Tyrosine Kinase/RTK
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close